We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Ombudsman Review Leads to Changes in EMA Pediatric Trials Waiver Process
EU Ombudsman Review Leads to Changes in EMA Pediatric Trials Waiver Process
August 9, 2013
As it pushes industry to share more clinical trial data, the European Medicines Agency is promising to shed more light on its pediatric trials waiver process, the EU’s ombudsman says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor